Chief Commercial Officer, MRD · Adaptive Biotechnologies Corp (ADPT)

Nitin Sood

FY2021 is the first fiscal year CompBrief holds for Nitin Sood as a named executive officer of Adaptive Biotechnologies; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$6,389,270

Salary $187,833Stock awards $2,999,993

2nd of 4 named executive officers at Adaptive Biotechnologies by FY2021 total.

4 named officers on file for Adaptive Biotechnologies, FY2021

Nitin Sood’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • ADPT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Adaptive Biotechnologies’s whole pay program stands against its peers

  • Adaptive Biotechnologies’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ADPT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed January 1, 1900 (DEF 14A).

Free

Get Nitin Sood’s full pay file as a PDF — free

More than this page: up to 10 years of Nitin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Nitin Sood compensation by year

Adaptive Biotechnologies Summary Compensation Table · the one fiscal year held
In US dollars, as Adaptive Biotechnologies reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$187,833
Bonus$0
Stock awards$2,999,993
Option awards$3,113,382
Non-equity incentive$87,432
Pension and deferred compensation$0
All other$630
Total$6,389,270

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Adaptive Biotechnologies Corp DEF 14A filed January 1, 1900, accession 0001564590-22-015288, and prior-year filings.

How this page was built: the Adaptive Biotechnologies Corp filed document, accession 0001564590-22-015288. Every figure is read from that document and cited to the page and table it appears in. Filed January 1, 1900.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU64,809$1,818,541—
RSU32,404$909,256—
Option162,022—$30.86

Per the Outstanding Equity Awards at Fiscal Year-End table in Adaptive Biotechnologies Corp's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Adaptive Biotechnologies’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Harlan RobinsChief Scientific Officer$8,346,482
Nitin Sood · this pageChief Commercial Officer, MRD$6,389,270
Julie RubinsteinPresident and Chief Operating Officer$5,815,939
Chad CohenFormer Chief Financial Officer$2,911,839

The full Adaptive Biotechnologies compensation record

free company brief

This page is one person within Adaptive Biotechnologies's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Adaptive Biotechnologies proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Adaptive Biotechnologies's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nitin Sood's compensation dossier · One-time report. No refunds.